Vaccination Coverage, Timeliness and Adverse Events Following Immunization in Children with Medical Conditions — Shandong Province, China, 2023

by ToChinaMed

A recent study published in the China CDC Weekly sheds light on vaccination coverage and timeliness among children with special medical conditions in Shandong Province. The research, based on 2023 data, examines how underlying health issues affect routine childhood immunization rates and the safety profile of vaccines in this vulnerable population.

Study Overview and Key Objectives

Children with medical conditions such as congenital heart disease, premature birth, or neurological disorders often face barriers to timely vaccination. Healthcare providers and parents may hesitate due to concerns about potential adverse events. This study aimed to quantify vaccination coverage, assess delays, and monitor adverse events following immunization (AEFI) in these children compared to healthy peers. Researchers analyzed immunization records from the Shandong Provincial Immunization Information System, focusing on children born between 2017 and 2022 who had at least one recorded medical condition.

Vaccination Coverage: Gaps Identified

The findings reveal that overall vaccination coverage among children with medical conditions was lower than the general population. For most vaccines in China’s National Immunization Program (NIP), coverage rates in this group lagged by 5–15 percentage points. The widest gaps were observed for live attenuated vaccines, such as the measles-mumps-rubella (MMR) and Japanese encephalitis vaccines. This suggests persistent caution or contraindication concerns among clinicians and families.

Timeliness: Delays Are Common

Beyond coverage, the study highlighted significant delays in vaccine administration. Age-appropriate vaccination—receiving doses within the recommended time window—was markedly lower. For example, the timely completion of the three-dose hepatitis B vaccine series was achieved by only 68% of children with medical conditions, compared to over 85% in healthy children. Delays were most pronounced for vaccines scheduled in the first year of life, a critical period for disease prevention.

Adverse Events: Reassuring Safety Data

Importantly, the incidence of adverse events following immunization was not significantly higher in children with medical conditions than in the general population. The reported AEFI rate was 12.3 per 100,000 doses, with the vast majority being mild reactions such as fever or local injection-site swelling. No serious, life-threatening events were directly attributed to vaccination. This aligns with global evidence that most children with stable chronic conditions can be safely immunized.

Implications for Public Health Policy

The authors emphasize the need for clear, evidence-based immunization guidelines tailored to children with specific medical conditions. They call for improved training of healthcare workers to assess individual risks and benefits, rather than applying blanket contraindications. Strengthening catch-up vaccination programs and parental education could help close the immunity gap in this underserved group.

What This Means for International Patients

For families outside China considering pediatric care or vaccination services in the country, this study reflects a growing focus on safe immunization practices for medically complex children. While the data is specific to Shandong Province, it underscores China’s commitment to monitoring and improving vaccine safety standards—a factor that may reassure parents seeking comprehensive pediatric care abroad. As always, vaccination decisions should be made in consultation with a qualified healthcare provider familiar with the child’s full medical history.